Venture Investment Portfolio Summary with Realized and Unrealized Returns (2014)
Venture Investment Portfolio Summary with Realized and Unrealized Returns (2014) The document lists financial performance of various biotech and medical device companies in a private investment portfolio. It contains no direct references to high‑profile individuals, government agencies, or controversial transactions, offering only generic financial metrics that are already public in nature. Key insights: Shows realized vs. unrealized returns for dozens of therapeutic and device firms.; Highlights high multiples for a few companies (e.g., Cerexa, Interlace Medical).; Aggregates total cost, realized value, unrealized value, and IRR for the portfolio.
Summary
Venture Investment Portfolio Summary with Realized and Unrealized Returns (2014) The document lists financial performance of various biotech and medical device companies in a private investment portfolio. It contains no direct references to high‑profile individuals, government agencies, or controversial transactions, offering only generic financial metrics that are already public in nature. Key insights: Shows realized vs. unrealized returns for dozens of therapeutic and device firms.; Highlights high multiples for a few companies (e.g., Cerexa, Interlace Medical).; Aggregates total cost, realized value, unrealized value, and IRR for the portfolio.
Tags
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.